Pluristem Therapeutics, Inc. (PSTI.OB) Approved for Listing on NASDAQ Capital Market
Pluristem Therapeutics Inc. (PSTI.OB), a leading bio-therapeutics company, announced that NASDAQ has approved the company's application to list their common stock on the NASDAQ Capital Market. The Company's common stock will begin trading on this market December 10, 2007 under the symbol PSTI. Zami Aberman, Pluristem's President and CEO, commented, "Pluristem is proud to begin trading on the NASDAQ Capital Market system. We believe that NASDAQ is the right platform to support our business growth aspirations. I am confident that our listing will facilitate broader interest in our common stock from both institutional and individual investors." The NASDAQ listing approval…